PROCEEDINGS ABSTRACT |
open access
Novel thiadiazole–thiourea hybrids targeting the vascular endothelial growth factor receptor 2: design, synthesis, characterization, and in silico assessment
Noora A. Al-Jubouri*, Shaker A. Abdul Hussein, Hussam W. Al-Humadi
College of Pharmacy, University of Babylon, Hillah, Iraq (NAA, HWA) ▪ Department of Pharmaceutical Chemistry, College of Pharmacy, University of Babylon, Hillah, Iraq (SAAH)
*corresponding author (pha155.noora.ali@student.uobabylon.edu.iq)
Received: 12 April 2026; Revised: 26 May 2026; Accepted: 28 June 2026; Published: 23 July 2026
DOI: 10.5281/zenodo.21504399
Full-text proceedings abstract: PDF
Keywords: anticancer; molecular docking; 1,3,4-thiadiazole; thiourea; VEGFR-2
Al-Jubouri N. A., Abdul Hussein S. A., Al-Humadi H. W.: Novel thiadiazole–thiourea hybrids targeting the vascular endothelial growth factor receptor 2: design, synthesis, characterization, and in silico assessment. Colloq. Erud. 1: 79–80 (2026).
https://doi.org/10.5281/zenodo.21504399
PREVIOUS PROCEEDINGS ABSTRACT ▪ VOLUME 1 (2026) ▪ NEXT PROCEEDINGS ABSTRACT